Below are the earnings highlights for Ligand Pharmaceuticals Inc (LGND):
Earnings: -$51.911 million in Q2 vs. $2.290 million in the same period last year.
EPS: -$2.88 in Q2 vs. $0.13 in the same period last year.
Excluding items, Ligand Pharmaceuticals Inc reported adjusted earnings of $25.833 million or $1.40 per share for the period.
Analysts projected $1.06 per share
Revenue: $41.531 million in Q2 vs. $26.366 million in the same period last year.
-Guidance:
Full year EPS guidance: $5.00 to $5.50
Full year revenue guidance: $140 - $157 Mln
For comments and feedback: editorial@rttnews.com